BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10415716)

  • 1. Engineering of selective TIMPs.
    Nagase H; Meng Q; Malinovskii V; Huang W; Chung L; Bode W; Maskos K; Brew K
    Ann N Y Acad Sci; 1999 Jun; 878():1-11. PubMed ID: 10415716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1' residue of substrate.
    Meng Q; Malinovskii V; Huang W; Hu Y; Chung L; Nagase H; Bode W; Maskos K; Brew K
    J Biol Chem; 1999 Apr; 274(15):10184-9. PubMed ID: 10187802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases.
    Huang W; Meng Q; Suzuki K; Nagase H; Brew K
    J Biol Chem; 1997 Aug; 272(35):22086-91. PubMed ID: 9268350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.
    Hamze AB; Wei S; Bahudhanapati H; Kota S; Acharya KR; Brew K
    Protein Sci; 2007 Sep; 16(9):1905-13. PubMed ID: 17660250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase.
    Lee MH; Rapti M; Murphy G
    J Biol Chem; 2003 Oct; 278(41):40224-30. PubMed ID: 12869573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
    Nagase H; Brew K
    Biochem Soc Symp; 2003; (70):201-12. PubMed ID: 14587293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
    EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2.
    Maskos K; Lang R; Tschesche H; Bode W
    J Mol Biol; 2007 Mar; 366(4):1222-31. PubMed ID: 17196980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations.
    Butler GS; Hutton M; Wattam BA; Williamson RA; Knäuper V; Willenbrock F; Murphy G
    J Biol Chem; 1999 Jul; 274(29):20391-6. PubMed ID: 10400663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into MMP-TIMP interactions.
    Bode W; Fernandez-Catalan C; Grams F; Gomis-Rüth FX; Nagase H; Tschesche H; Maskos K
    Ann N Y Acad Sci; 1999 Jun; 878():73-91. PubMed ID: 10415721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
    Troeberg L; Tanaka M; Wait R; Shi YE; Brew K; Nagase H
    Biochemistry; 2002 Dec; 41(50):15025-35. PubMed ID: 12475252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.
    Park HI; Jin Y; Hurst DR; Monroe CA; Lee S; Schwartz MA; Sang QX
    J Biol Chem; 2003 Dec; 278(51):51646-53. PubMed ID: 14532275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP-TIMP interaction depends on residue 2 in TIMP-4.
    Stratmann B; Farr M; Tschesche H
    FEBS Lett; 2001 Nov; 507(3):285-7. PubMed ID: 11696356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue inhibitors of metalloproteinases: evolution, structure and function.
    Brew K; Dinakarpandian D; Nagase H
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):267-83. PubMed ID: 10708863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drosophila TIMP is a potent inhibitor of MMPs and TACE: similarities in structure and function to TIMP-3.
    Wei S; Xie Z; Filenova E; Brew K
    Biochemistry; 2003 Oct; 42(42):12200-7. PubMed ID: 14567681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme.
    Stracke JO; Hutton M; Stewart M; Pendás AM; Smith B; López-Otin C; Murphy G; Knäuper V
    J Biol Chem; 2000 May; 275(20):14809-16. PubMed ID: 10809722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
    Raeeszadeh-Sarmazdeh M; Greene KA; Sankaran B; Downey GP; Radisky DC; Radisky ES
    J Biol Chem; 2019 Jun; 294(24):9476-9488. PubMed ID: 31040180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzyme.
    Lee MH; Rapti M; Murphy G
    J Biol Chem; 2005 Apr; 280(16):15967-75. PubMed ID: 15713681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.